Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2023-02-22 Director's Dealing
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Arctic Bioscience - Mandatory notification of trade' and explicitly states that the COO bought shares. It references disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19, which governs insider trading notifications. This directly corresponds to the definition of Director's Dealing (DIRS), which covers personal share transactions by directors and executives (insider trades). Although it mentions an 'attached notification,' the core content is the trade disclosure itself, making DIRS a more specific fit than RPA or RNS.
2023-02-22 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 98% confidence The document text is titled "Arctic Bioscience - Meldepliktig handel" (Mandatory Trading) and explicitly states that Per Christian Sæbø, COO, bought 4,500 shares. It references MAR (Market Abuse Regulation) Article 19 and the Norwegian Securities Trading Act § 5-12, which mandate disclosure for insider transactions. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). The document is short and mentions an attached notification ("Jf. vedlagt melding om handel"), but the core content is the transaction disclosure itself, making 'DIRS' the most specific classification over a general RPA or RNS.
2023-02-22 Norwegian
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 99% confidence The document text is a structured notification template detailing a transaction conducted by a person discharging managerial responsibilities (CFO Jone R. Slinning) in the shares of the issuer (Arctic Bioscience AS). Specifically, it reports a 'Share Purchase' transaction, including the price, volume, date (2023-02-16), and instrument identification code. This content directly matches the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2023-02-16 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 99% confidence The document text is a structured notification template detailing a transaction conducted by a person discharging managerial responsibilities (CFO Jone R. Slinning) in the shares of the issuer (Arctic Bioscience AS). Specifically, it reports a 'Share Purchase' transaction, including the price, volume, date (2023-02-16), and instrument identification code. This content directly matches the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2023-02-16 Norwegian
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Arctic Bioscience - Mandatory notification of trade' and explicitly details a share purchase by the CFO, Jone R. Slinning. It cites regulatory requirements, specifically 'Regulation EU 596/2014 (MAR) article 19 number 3', which governs the disclosure of transactions by persons discharging managerial responsibilities (insiders). This directly corresponds to the definition of Director's Dealing (DIRS), which covers personal share transactions by directors and executives (insider trades). The document length is short (1544 chars) and it mentions an 'attached notification', but the core content *is* the mandatory disclosure itself, making DIRS a more specific fit than RPA or RNS.
2023-02-16 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 98% confidence The document text is titled 'Arctic Bioscience - Meldepliktig handel' (Mandatory Trading) and details a transaction where the CFO, Jone R. Slinning, bought shares. It explicitly mentions compliance with MAR (Market Abuse Regulation) Article 19 and the Norwegian Securities Trading Act § 5-12, which govern insider trading and director's dealings. This directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions an attached notification ('Jf. vedlagt melding om handel'), the core content is the report of the transaction itself, not just an announcement of a report's publication, making DIRS the most specific fit over RPA or RNS.
2023-02-16 Norwegian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.